{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,11]],"date-time":"2026-03-11T07:12:40Z","timestamp":1773213160630,"version":"3.50.1"},"reference-count":18,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,3,10]]},"DOI":"10.7759\/cureus.104972","type":"journal-article","created":{"date-parts":[[2026,3,10]],"date-time":"2026-03-10T09:27:17Z","timestamp":1773134837000},"source":"Crossref","is-referenced-by-count":0,"title":["Successful Outcome of Acute Promyelocytic Leukemia Complicated by Bone Marrow Necrosis and Posterior Reversible Encephalopathy Syndrome, During Treatment With an All-Trans Retinoic Acid Plus Arsenic Trioxide-Based Regimen"],"prefix":"10.7759","author":[{"given":"Theodora  M","family":"Venou","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maria","family":"Mainou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Konstantina","family":"Voura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ester  S","family":"Mbonde Mouangue","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nicolaos","family":"Flaris","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Efthymia","family":"Vlachaki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1038\/modpathol.3880174","article-title":"Pathologic, cytogenetic and molecular assessment of acute promyelocytic leukemia patients treated with arsenic trioxide (As2O3)","volume":"13","author":"Zhang T","year":"2000","unstructured":"Zhang T, Westervelt P, Hess JL. Pathologic, cytogenetic and molecular assessment of acute promyelocytic leukemia patients treated with arsenic trioxide (As2O3). Mod Pathol. 2000, 13:954-61. 10.1038\/modpathol.3880174","journal-title":"Mod Pathol"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1097\/PAT.0b013e3283489087","article-title":"Reversible bone marrow necrosis after all-trans retinoic acid induction therapy for acute promyelocytic leukaemia","volume":"43","author":"Lakhwani S","year":"2011","unstructured":"Lakhwani S, Raya JM, Gonz\u00e1lez-Brito G, \u00c1lvarez-Arg\u00fcelles H, Brito ML, Hern\u00e1ndez-Nieto L. Reversible bone marrow necrosis after all-trans retinoic acid induction therapy for acute promyelocytic leukaemia. Pathology. 2011, 43:515-17. 10.1097\/PAT.0b013e3283489087","journal-title":"Pathology"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1002\/ajh.24074","article-title":"Bone marrow necrosis in acute leukemia: Clinical characteristic and outcome","volume":"90","author":"Badar T","year":"2015","unstructured":"Badar T, Shetty A, Bueso-Ramos C, et al.. Bone marrow necrosis in acute leukemia: Clinical characteristic and outcome. Am J Hematol. 2015, 90:769-73. 10.1002\/ajh.24074","journal-title":"Am J Hematol"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.639","article-title":"Extensive bone marrow necrosis and osteolytic lesions in a case of acute myeloid leukemia transformed from polycythemia vera","volume":"8","author":"Chambers I","year":"2016","unstructured":"Chambers I, Truong P, Kallail KJ, Palko W. Extensive bone marrow necrosis and osteolytic lesions in a case of acute myeloid leukemia transformed from polycythemia vera. Cureus. 2016, 8:e639. 10.7759\/cureus.639","journal-title":"Cureus"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1007\/s40487-017-0041-7","article-title":"Bone marrow necrosis in newly diagnosed acute leukemia: two case reports and review of the literature","volume":"5","author":"Quintela A","year":"2017","unstructured":"Quintela A, Sujobert P, Tigaud I, et al.. Bone marrow necrosis in newly diagnosed acute leukemia: two case reports and review of the literature. Oncol Ther. 2017, 5:111-18. 10.1007\/s40487-017-0041-7","journal-title":"Oncol Ther"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1155\/2020\/8889850","article-title":"Extensive bone marrow necrosis: a rare presentation of acute lymphoblastic leukaemia","volume":"2020","author":"Ranathunga I","year":"2020","unstructured":"Ranathunga I, Muthumala NR, Kulathilake HW, Weerasinghe S, Shyamali NL. Extensive bone marrow necrosis: a rare presentation of acute lymphoblastic leukaemia. Case Rep Hematol. 2020, 2020:8889850. 10.1155\/2020\/8889850","journal-title":"Case Rep Hematol"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.2169\/internalmedicine.5815-20","article-title":"Recurrence of acute lymphoblastic leukemia with bone marrow necrosis: A case report and review of the literature on the MRI features of bone marrow necrosis","volume":"60","author":"Harada N","year":"2021","unstructured":"Harada N, Nishimoto M, Ikemoto A, et al.. Recurrence of acute lymphoblastic leukemia with bone marrow necrosis: A case report and review of the literature on the MRI features of bone marrow necrosis. Intern Med. 2021, 60:1083-88. 10.2169\/internalmedicine.5815-20","journal-title":"Intern Med"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1111\/j.0902-4441.2003.00206.x","article-title":"Bone marrow necrosis in a patient with acute promyelocytic leukemia during re-induction therapy with arsenic trioxide","volume":"72","author":"Ishitsuka K","year":"2004","unstructured":"Ishitsuka K, Shirahashi A, Iwao Y, et al.. Bone marrow necrosis in a patient with acute promyelocytic leukemia during re-induction therapy with arsenic trioxide. Eur J Haematol. 2004, 72:280-84. 10.1111\/j.0902-4441.2003.00206.x","journal-title":"Eur J Haematol"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1002\/(sici)1099-1069(199702)15:1<13::aid-hon593>3.0.co;2-s","article-title":"Exacerbation of coagulopathy with concurrent bone marrow necrosis, hepatic and renal dysfunction secondary to all-trans retinoic acid therapy for acute promyelocytic leukemia","volume":"15","author":"Cull GM","year":"1997","unstructured":"Cull GM, Eikelboom JW, Cannell PK. Exacerbation of coagulopathy with concurrent bone marrow necrosis, hepatic and renal dysfunction secondary to all-trans retinoic acid therapy for acute promyelocytic leukemia. Hematol Oncol. 1997, 15:13-17. 10.1002\/(sici)1099-1069(199702)15:1&lt;13::aid-hon593&gt;3.0.co;2-s","journal-title":"Hematol Oncol"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.3960\/jslrt.24015","article-title":"TTMV::RARA-positive acute promyelocytic leukemia with marrow necrosis and central nervous system involvement at disease recurrence","volume":"64","author":"Wang Z","year":"2024","unstructured":"Wang Z, Chen J, Meng J, Zhao M, Liu H, Xiao X. TTMV::RARA-positive acute promyelocytic leukemia with marrow necrosis and central nervous system involvement at disease recurrence. J Clin Exp Hematop. 2024, 64:237-41. 10.3960\/jslrt.24015","journal-title":"J Clin Exp Hematop"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1007\/s10637-025-01556-1","article-title":"Understanding the differentiation syndrome in acute promyelocytic leukemia: a comprehensive updated review","volume":"43","author":"Damaj N","year":"2025","unstructured":"Damaj N, Elias N, Zeidan T, Kattan J. Understanding the differentiation syndrome in acute promyelocytic leukemia: a comprehensive updated review. Invest New Drugs. 2025, 43:750-56. 10.1007\/s10637-025-01556-1","journal-title":"Invest New Drugs"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.4103\/ejh.ejh_6_21","article-title":"Posterior reversible encephalopathy syndrome during management of hematological disorders.","volume":"46","author":"Gupta G","year":"2021","unstructured":"Gupta G, Seth T, Garg V, et al.. Posterior reversible encephalopathy syndrome during management of hematological disorders. . Egypt J Haematol. 2021, 46:160-65. 10.4103\/ejh.ejh_6_21","journal-title":"Egypt J Haematol"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1159\/000281063","article-title":"Non-lethal bone marrow necrosis under first-line arsenic trioxide therapy in acute promyelocytic leukaemia","volume":"123","author":"Ianotto JC","year":"2010","unstructured":"Ianotto JC, Tempescul A, Eveillard JR, Charles F, Berthou C. Non-lethal bone marrow necrosis under first-line arsenic trioxide therapy in acute promyelocytic leukaemia. Acta Haematol. 2010, 123:146-47. 10.1159\/000281063","journal-title":"Acta Haematol"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.2169\/internalmedicine.8859-21","article-title":"Complete bone marrow necrosis with charcot-leyden crystals caused by myeloid neoplasm with mutated NPM1 and TET2","volume":"61","author":"Saito K","year":"2022","unstructured":"Saito K, Sato T, Notohara K, Nannya Y, Ogawa S, Ueda Y. Complete bone marrow necrosis with charcot-leyden crystals caused by myeloid neoplasm with mutated NPM1 and TET2. Intern Med. 2022, 61:3265-69. 10.2169\/internalmedicine.8859-21","journal-title":"Intern Med"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1002\/ajh.2830470111","article-title":"Bone marrow necrosis in two patients with acute promyelocytic leukemia during treatment with all-trans retinoic acid","volume":"47","author":"Limentani SA","year":"1994","unstructured":"Limentani SA, Pretell JO, Potter D, DuBois JS, Daoust PR, Spieler PS, Miller KB. Bone marrow necrosis in two patients with acute promyelocytic leukemia during treatment with all-trans retinoic acid. Am J Hematol. 1994, 47:50-55. 10.1002\/ajh.2830470111","journal-title":"Am J Hematol"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1007\/s00277-021-04720-8","article-title":"Bone marrow necrosis as complication of treatment with all-trans retinoic acid and arsenic trioxide: case report and implications for treatment","volume":"101","author":"Hazenberg CL","year":"2022","unstructured":"Hazenberg CL, Diepstra A, Santing M, Huls GA, Ammatuna E. Bone marrow necrosis as complication of treatment with all-trans retinoic acid and arsenic trioxide: case report and implications for treatment. Ann Hematol. 2022, 101:1133-34. 10.1007\/s00277-021-04720-8","journal-title":"Ann Hematol"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1016\/j.pathol.2024.09.012","article-title":"Pain crisis complicating severe bone marrow necrosis during induction for acute promyelocytic leukaemia","volume":"57","author":"Goodall E","year":"2025","unstructured":"Goodall E, Tedjaseputra A, Hui C, Walker P, Shortt J. Pain crisis complicating severe bone marrow necrosis during induction for acute promyelocytic leukaemia. Pathology. 2025, 57:375-77. 10.1016\/j.pathol.2024.09.012","journal-title":"Pathology"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1002\/pbc.26461","article-title":"First experience of the AML-Berlin-Frankfurt-M\u00fcnster group in pediatric patients with standard-risk acute promyelocytic leukemia treated with arsenic trioxide and all-trans retinoid acid","volume":"64","author":"Creutzig U","year":"2017","unstructured":"Creutzig U, Dworzak MN, Bochennek K, et al.. First experience of the AML-Berlin-Frankfurt-M\u00fcnster group in pediatric patients with standard-risk acute promyelocytic leukemia treated with arsenic trioxide and all-trans retinoid acid. Pediatr Blood Cancer. 2017, 64:10.1002\/pbc.26461","journal-title":"Pediatr Blood Cancer"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/453941-successful-outcome-of-acute-promyelocytic-leukemia-complicated-by-bone-marrow-necrosis-and-posterior-reversible-encephalopathy-syndrome-during-treatment-with-an-all-trans-retinoic-acid-plus-arsenic-trioxide-based-regimen","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,10]],"date-time":"2026-03-10T09:27:18Z","timestamp":1773134838000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/453941-successful-outcome-of-acute-promyelocytic-leukemia-complicated-by-bone-marrow-necrosis-and-posterior-reversible-encephalopathy-syndrome-during-treatment-with-an-all-trans-retinoic-acid-plus-arsenic-trioxide-based-regimen"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,10]]},"references-count":18,"URL":"https:\/\/doi.org\/10.7759\/cureus.104972","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2026,3,10]]}}}